SOLICITATION NOTICE
66 -- Next Generation Sequencing (NGS) Instrument
- Notice Date
- 9/2/2014
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Commerce, National Institute of Standards and Technology (NIST), Acquisition Management Division, 100 Bureau Drive, Building 301, Room B130, Gaithersburg, Maryland, 20899-1410, United States
- ZIP Code
- 20899-1410
- Solicitation Number
- SB1341-14-RQ-0800
- Archive Date
- 9/27/2014
- Point of Contact
- Kim S Stavish, Phone: 301-975-2672, Andrea A Parekh, Phone: (301)975-6984
- E-Mail Address
-
kim.stavish@nist.gov, andrea.parekh@nist.gov
(kim.stavish@nist.gov, andrea.parekh@nist.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Institute of Standards and Technology (NIST) Acquisition Management Division, on behalf of the Biomolecular Measurement Division, Material Measurement Laboratory, intends to negotiate, on a sole source basis, under authority of FAR 13.106-1(b)(1), with Illumina, Inc., San Diego, CA, for the purchase of a Next Generation Sequencing (NGS) Instrument to be located at NIST, 100 Bureau Drive, Gaithersburg, MD. Sole Source determination is based on the following: The Applied Genetics Group in the Biomolecular Measurement Division at NIST conducts research into the use of next generation sequencing (NGS) for forensic DNA biometrics and human identification (HID). NIST will evaluate NGS technology's suitability for use in forensics through assessment in the areas of accuracy, precision, sensitivity, concordance with current methods, and improved capabilities for HID. Currently the U.S. national DNA database, CODIS, contains over 13 million DNA profiles. These profiles are in the form of short tandem repeat (STR) genotypes for a core set of markers defined by the Federal Bureau of Investigation (FBI). The forensic community has demonstrated growing interest in the use of massively parallel sequencing (a.k.a. next generation sequencing or NGS) to generate forensic DNA profiles. NGS technology has potential to produce STR profiles which are compatible with the current CODIS database while at the same time enabling analysis of additional DNA markers, such as single nucleotide polymorphisms (SNPs) simultaneously. Therefore, the work performed at NIST requires an NGS platform with the capability to to perform multiplexed analysis of short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) simultaneously. Illumina, Inc, is the only known vendor capable of providing the required NGS Platform (Model MiSeq FGx) that meets the Government's minimum requirements and enables the required capabilities of combining STRs and SNPs. Illumina, Inc., is the sole manufacturer and distributor. The North American Industry Classification System (NAICS) code for this acquisition is 334516, and the size standard is 500 employees. No solicitation package will be issued. This notice of intent is not a request for competitive quotations; however, the Government will consider responses received by September 12, 2014, 3:30 p.m. EST. A determination by the Government not to compete the proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DOC/NIST/AcAsD/SB1341-14-RQ-0800/listing.html)
- Place of Performance
- Address: TBD, United States
- Record
- SN03491395-W 20140904/140902234915-f285092bdc44e0a24bb5986d5b600621 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |